Asati V - Search Results

1

Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.

Patel P, Wahan SK, Vishakha S, Kurmi BD, Gupta GD, Rajak H, Asati V. Patel P, et al. Among authors: asati v. Curr Cancer Drug Targets. 2022;23(1):47-70. doi: 10.2174/1568009622666220624090542. Curr Cancer Drug Targets. 2022. PMID: 35747969 Review.

2

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Asati V, Anant A, Patel P, Kaur K, Gupta GD. Asati V, et al. Eur J Med Chem. 2021 Dec 5;225:113781. doi: 10.1016/j.ejmech.2021.113781. Epub 2021 Aug 18. Eur J Med Chem. 2021. PMID: 34438126 Review.

3

Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships.

Asati V, Anant A, Mahapatra DK, Bharti SK. Asati V, et al. Mini Rev Med Chem. 2022;22(16):2146-2165. doi: 10.2174/1389450123666220202154757. Mini Rev Med Chem. 2022. PMID: 35114920 Review.

4

Structural aspects of triazole derivatives as HSP90 inhibitors for the treatment of cancer: in silico studies.

Dhiman S, Saha M, Ali A, Ali A, Gupta GD, Asati V. Dhiman S, et al. Among authors: asati v. J Biomol Struct Dyn. 2023 Jul;41(10):4756-4769. doi: 10.1080/07391102.2022.2083686. Epub 2022 Jun 6. J Biomol Struct Dyn. 2023. PMID: 35665636

5

Recent Updates on Indole Derivatives as Kinase Inhibitors in the Treatment of Cancer.

Asati V, Bhupal R, Bhattacharya S, Kaur K, Gupta GD, Pathak A, Mahapatra DK. Asati V, et al. Anticancer Agents Med Chem. 2023;23(4):404-416. doi: 10.2174/1871520622666220607143040. Anticancer Agents Med Chem. 2023. PMID: 35674295 Review.

6

An Investigative Review for Pharmaceutical Analysis of Fenofibrate.

Saha M, Dhiman S, Gupta GD, Asati V. Saha M, et al. Among authors: asati v. J Chromatogr Sci. 2023 May 30;61(5):494-504. doi: 10.1093/chromsci/bmac072. J Chromatogr Sci. 2023. PMID: 36097790 Review.

7

Recent Advances of PI3 Kinase Inhibitors: Structure Anticancer Activity Relationship Studies.

Asati V, Anant A, Mahapatra DK, Bharti SK. Asati V, et al. Mini Rev Med Chem. 2022 Feb 2. doi: 10.2174/1389450123666220202154757. Online ahead of print. Mini Rev Med Chem. 2022. PMID: 36471584

8

Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent.

Ayaz MS, Bhupal R, Sharma P, Sahu A, Singh P, Gupta GD, Asati V. Ayaz MS, et al. Among authors: asati v. Anticancer Agents Med Chem. 2023;23(8):900-921. doi: 10.2174/1871520623666230110114620. Anticancer Agents Med Chem. 2023. PMID: 36627781 Review.

9

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach.

Baweja GS, Gupta S, Kumar B, Patel P, Asati V. Baweja GS, et al. Among authors: asati v. Mol Divers. 2024 Jun;28(3):1823-1845. doi: 10.1007/s11030-023-10634-6. Epub 2023 Mar 28. Mol Divers. 2024. PMID: 36977955 Free PMC article. Review.

10

Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.

Ritu, Sharma P, Gupta GD, Asati V. Ritu, et al. Among authors: asati v. Bioorg Chem. 2023 Oct;139:106750. doi: 10.1016/j.bioorg.2023.106750. Epub 2023 Jul 23. Bioorg Chem. 2023. PMID: 37499530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters